| Literature DB >> 33834426 |
Shun Yamamuro1, Hiroshi Negishi2, Katsunori Shijo2, Atsuo Yoshino2.
Abstract
Entities:
Mesh:
Substances:
Year: 2021 PMID: 33834426 PMCID: PMC8443500 DOI: 10.1007/s13760-021-01667-5
Source DB: PubMed Journal: Acta Neurol Belg ISSN: 0300-9009 Impact factor: 2.396
Fig. 1a–c Eye movement findings before surgery (a right gaze, b primary possession, c left gaze). d–f Eye movement findings after glucocorticoid treatment (d right gaze, e primary possession, f left gaze)
Fig. 2a Preoperative axial gadolinium-enhanced T1-weighted MR imaging. b Postoperative axial gadolinium-enhanced T1-weighted MR imaging. c Post-glucocorticoid treatment axial gadolinium-enhanced T1-weighted MR imaging). d Pathological findings via hematoxylin and eosin staining (original magnification × 100). e, f Pathological findings via immunohistochemical staining of IgG (e original magnification × 100) and IgG4 (f original magnification × 50)